March 05, 2018
Safety Analysis of Leishmania Vaccine Used in a Randomized Canine Vaccine/Immunotherapy Trial
In Leishmania infantum–endemic countries, controlling infection within dogs, the domestic reservoir, is critical to public health. There is a need for safe vaccines that prevent canine progression with disease and transmission to others. Protective vaccination against Leishmania requires mounting a strong, inflammatory, Type 1 response. Three commercially available canine vaccines on the global veterinary market use saponin or inflammatory antigen components (Letifend) as a strong pro-inflammatory adjuvant. There is very little information detailing safety of saponin as an adjuvant in field trials. Safety analyses for the use of vaccine as an immunotherapeutic in asymptomatically infected animals are completely lacking. Leishmania infantum, the causative agent of canine leishmaniasis, is enzootic within U.S. hunting hounds. We assessed the safety of LeishTec® after use in dogs from two different clinical states: 1) without clinical signs and tested negative on polymerase chain reaction and serology or 2) without clinical signs and positive for at least one Leishmania diagnostic test. Vaccine safety was assessed after all three vaccinations to quantify the number and severity of adverse events. Vaccinated animals had an adverse event rate of 3.09%, whereas placebo animals had 0.68%. Receiving vaccine was correlated with the occurrence of mild, site-specific, reactions. Occurrence of severe adverse events was not associated with having received vaccine. Infected, asymptomatic animals did not have a higher rate of adverse events. Use of vaccination is, therefore, likely to be safe in infected, asymptomatic animals.
Read the full article in The American of Tropical Medicine and Hygiene.
More from CNAS
-
The U.S. Military Needs to Relearn Nuclear Signaling
Commentary
This deterioration matters because beyond the quantity and quality of the United States’ nuclear forces, nuclear deterrence will rest on the country’s ability to effectively s...
By Philip Sheers
-
Sharper: America’s Edge
Commentary
A volatile global security environment requires the United States and its allies to develop new tactics and capabilities to deal with novel global threats. On June 3, policyma...
By Charles Horn
-
Why China’s Amphibious ‘Invasion Platforms’ Are Troubling Sign for Taiwan
Video
Beijing’s new ships can land on beaches and link to form massive mobile piers. Analysts, including Tom Shugart from Center for a New American Security, say they’re intended to...
By Tom Shugart
-
"From Production Lines to Front Lines," with Becca Wasser and Philip Sheers of CNAS
Podcast
In this episode of Building the Base, Hondo Geurts and Lauren Bedula are joined by Becca Wasser and Philip Sheers from the Center for New American Security (CNAS) to discuss t...
By Becca Wasser & Philip Sheers
